Sunny Deol's 'Jaat' opened to modest box office numbers and mixed reviews. Despite this, Hema Malini and Esha Deol expressed happiness over the audience's response. Sunny has upcoming projects ...

Hema Malini and Esha Deol recently attended an event in Mumbai. Speaking on the sidelines of the event, the mother-daughter duo spoke about Jaat and how veteran actor Dharmendra has received it. Hema ...

Esha added, “I am so happy and its all his hard work and logo ka pyaar he unke liye itna toh I am so happy that the film has opened big (This is all because of his hard work and the love of his ...

Veteran actress and politician Hema Malini praised Sunny Deol’s performance in the film Jaat. The film has been riding high on the success as the audience calls it a pure masala entertainer. During an ...

In a heartwarming moment, Laapataa Ladies actor Nitanshi Goel paused her ramp walk during a fashion show in Mumbai to pay her respects to veteran actor Hema Malini. She stopped mid-walk to touch ...

One of the most adorable mother-daughter duos, Esha Deol and Hema Malini, stepped out in Mumbai last night and we can’t keep calm. Showcasing their charm, the pair was twinning in red as they arrived ...

Veteran actress and Member of Parliament, Hema Malini, has expressed immense joy and pride over the success of her stepson Sunny Deol’s latest film, Jaat. The action-packed entertainer ...

With JOBEVNE, Biocon Biologics further cements its position in the U.S. oncology biosimilars market, where it already offers OGIVRI (Trastuzumab-dkst) and FULPHILA (Pegfilgrastim-jmdb).

The approval bolsters the company’s biosimilar oncology portfolio in the US, which includes Fulphila (Pegfilgrastim-jmdb) and Ogivri (Trastuzumab-dkst). The company has been marketing bevacizumab ...

The approval of JOBEVNE expands Biocon Biologics’ biosimilar oncology portfolio in the United States, which also includes OGIVRI (Trastuzumab-dkst) and FULPHILA (Pegfilgrastim-jmdb). The Company also ...

New York based distributor Dekanalog has made three new acquisitions for its 2025 theatrical slate: “Hema Hema: Sing Me a Song While I Wait” by Khyentse Norbu, “Redlands” by John Brian ...

This is a significant addition to the company’s growing cancer treatment portfolio in the U.S., which already includes OGIVRI (Trastuzumab-dkst) and FULPHILA (Pegfilgrastim-jmdb). The company also ...